Skip to main content

Table 2 Multivariable analysis of in hospital mortality and orotracheal intubation in the complete cohort (n = 1170)

From: Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies

Characteristic Mortality risk factors OR (CI 95%) Orotracheal intubation risk factors OR (CI 95%) Covariables included in the logistic analysis
Age
Diabetes Mellitus
Obesity
CKD
1.142 (1.03–1.18)
NS
NS
1.042 (1.02–1.06)
3.29 (1.99–5.47)
2.158 (1.13–4.11)
3.1 (1.22–7.82)
Age and gender and all comorbidities
Prisma
NEWS/PEWS
CLHO/HCQ
12.06 (1.31–110.81)
1.34 (1.06–1.7)
10.46 91.23–88.52)
NS
1.34 (1.06–1.69)
10.16 (1.2–86.02)
Orotracheal intubation, prona, prisma, NEWS/PEWS
Vasoactive drug and CLHO/HCQ
  1. NS, not significant; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; NEWS/PEWS, National Early Warning Score/Pediatric Early Warning Score; Prisma, prisma hemodialysis machine; Prona, prone position; CLHO/HCQ, Chloroquine /hydroxychloroquine